AGGF1

AGGF1
Identifiers
AliasesAGGF1, GPATC7, GPATCH7, HSU84971, HUS84971, VG5Q, angiogenic factor with G-patch and FHA domains 1
External IDsOMIM: 608464; MGI: 1913799; HomoloGene: 41220; GeneCards: AGGF1; OMA:AGGF1 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_018046
NM_013303
NM_138490

NM_025630

RefSeq (protein)

NP_060516

NP_079906

Location (UCSC)Chr 5: 77.03 – 77.07 MbChr 13: 95.49 – 95.51 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Angiogenic factor with G patch and FHA domains 1 is a protein that in humans is encoded by the AGGF1 gene.[5][6][7]

AGGF1 is a human gene that functions as an angiogenic factor with a G-patch and forkhead-associated domain.[8] This gene is predominantly expressed in activated, plump endothelial cells and acts to regulate angiogenesis and vascular development.[9] AGGF1 is known to interact with a wide range of proteins involved in vascular development.[10] Mutations to AGGF1 have been implicated in multiple cancers and is known to cause the rare congenital condition, Klippel-Trenaunay syndrome.[9][11][12]

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000164252Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000021681Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Hu Y, Li L, Seidelmann SB, Timur AA, Shen PH, Driscoll DJ, Wang QK (September 2008). "Identification of association of common AGGF1 variants with susceptibility for Klippel-Trenaunay syndrome using the structure association program". Annals of Human Genetics. 72 (Pt 5): 636–43. doi:10.1111/j.1469-1809.2008.00458.x. PMC 2602961. PMID 18564129.
  6. ^ Gutierrez S, Magano L, Delicado A, Mori MA, de Torres ML, Fernández L, Palomares M, Fernández E, Tarduchy GR, Molano J, Gracia R, Pajares IL, Lapunzina P (December 2006). "The G397A (E133K) change in the AGGF1 (VG5Q) gene is a single nucleotide polymorphism in the Spanish population". American Journal of Medical Genetics. Part A. 140 (24): 2832–3. doi:10.1002/ajmg.a.31532. PMID 17103452. S2CID 19068189.
  7. ^ "Entrez Gene: AGGF1 angiogenic factor with G patch and FHA domains 1".
  8. ^ Cite error: The named reference Zhan_2016 was invoked but never defined (see the help page).
  9. ^ a b Zhang T, Yao Y, Wang J, Li Y, He P, Pasupuleti V, Hu Z, Jia X, Song Q, Tian XL, Hu C, Chen Q, Wang QK (December 2016). "Haploinsufficiency of Klippel-Trenaunay syndrome gene Aggf1 inhibits developmental and pathological angiogenesis by inactivating PI3K and AKT and disrupts vascular integrity by activating VE-cadherin". Human Molecular Genetics. 25 (23): 5094–5110. doi:10.1093/hmg/ddw273. PMC 6078640. PMID 27522498.
  10. ^ Li L, Chen D, Li J, Wang X, Wang N, Xu C, Wang QK (January 2014). "Aggf1 acts at the top of the genetic regulatory hierarchy in specification of hemangioblasts in zebrafish". Blood. 123 (4): 501–8. doi:10.1182/blood-2013-07-514612. PMC 3901065. PMID 24277077.
  11. ^ Yao HH, Wang BJ, Wu Y, Huang Q (2017). "High Expression of Angiogenic Factor with G-Patch and FHA Domain1 (AGGF1) Predicts Poor Prognosis in Gastric Cancer". Medical Science Monitor. 23: 1286–1294. doi:10.12659/msm.903248. PMC 5362190. PMID 28289272.
  12. ^ Wang W, Li GY, Zhu JY, Huang DB, Zhou HC, Zhong W, Ji CS (April 2015). "Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma". Medical Oncology. 32 (4): 131. doi:10.1007/s12032-015-0574-2. PMID 25796501. S2CID 25099244.